MedTrace Logo

Precision Opioid Care After Cesarean Delivery (PRECISE-CD)

NCT05280743 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 341

Last updated 2024-07-05

No results posted yet for this study

Summary

The purpose of this research is to study serious clinical problems from surgical pain and the use of oxycodone or other opioids in women having a Cesarean Delivery to improve the safety and efficacy of surgical pain relief. This research will ultimately improve the safety and efficacy of surgical pain relief with opioids by preoperative risk predictions and personalized care with the right dose of the right analgesic for each patient.

Conditions

  • Cesarean Section Complications
  • Opioid Use

Interventions

DRUG

Oxycodone

exposure to opioids after Cesarean Section

Sponsors & Collaborators

  • Grace Lim, MD, MS

    lead OTHER

Principal Investigators

  • Grace Lim, MD MSc · University of Pittsburgh

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-28
Primary Completion
2023-09-24
Completion
2024-06-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05280743 on ClinicalTrials.gov